Abrysvo Vaccine Respiratory Syncytial Virus (RSV) Vaccine
ABRYSVO (RSV) Vaccine
Walk-ins are welcome, but appointments are served first.
Who We Vaccinate
ABRYSVO is FDA-approved to help prevent lower respiratory tract disease (LRTD) caused by RSV in adults 60+.
Priority groups include:
- Adults 75+
- Adults 60–74 at increased risk (chronic heart or lung disease, weakened immune system, severe obesity, severe diabetes, or residents of nursing homes/long-term care).
What Is RSV?
RSV is a highly contagious virus that infects the lungs and respiratory tract. It can cause more serious illness such as bronchiolitis and pneumonia, especially in vulnerable groups.
